ElMindA

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, ElMindA sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

ElMindA: 12 sponsored US clinical trials, none currently recruiting.

ElMindA sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. The most-studied condition in this pipeline is Healthy (Controls), with 1 trials.

Top-decile sponsor footprint

ElMindA ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED

Brain Network Activation Analysis in Epilepsy

NCT03265925
COMPLETED

Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment

NCT03265912
COMPLETED

Additional Post Hoc Analysis and Clinical Data Collection

NCT02860416
COMPLETED

Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials

NCT02418208
COMPLETED

Investigator Initiated Protocol for the: Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion and the Establishment of Normative Data in Youth and Adolescents Athletes

NCT02105935
COMPLETED

An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion

NCT01963247
COMPLETED

Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.

NCT01923441
COMPLETED

Normative Data of Brain Network Activation in Adolescents and Young Adults

NCT01671761
COMPLETED

A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion

NCT01673464
COMPLETED

Comparison of Brain Network Activation (BNA™) Analysis, Clinical Symptoms and Neuro-cognitive Performance in Concussed Children and Young Adults

NCT01532271
COMPLETED

Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion

NCT01535339
COMPLETED

Normative Data of Brain Network Activation in Adolescents and Young Adults

NCT01460394

Therapeutic Areas

Healthy (Controls) 1

How the ElMindA archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Healthy (Controls) (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

ElMindA: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

ElMindA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share ElMindAAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
ElMindA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

ElMindA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this ElMindA page

12 registered trials is a research-attention snapshot, not an endorsement of ElMindA or any single study.

  • None of ElMindA's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Healthy (Controls) is the condition ElMindA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy (Controls) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

ElMindA pipeline card: 12 registered trials from official public datasets.Report a data error.